CrisprBits
Type
startup
Founded
2020
Funding captured
$3.0m
Deals captured
1
About CrisprBits
CrisprBits is a biotechnology startup focused on developing CRISPR-based molecular diagnostics. The company builds diagnostic platforms and assays that leverage CRISPR gene-editing biology to detect pathogens and molecular signatures rapidly and with high sensitivity. Its offerings target clinical and point-of-care laboratories, aiming to commercialise scalable, manufacturable tests for infectious and other high-impact diseases, and to expand access to advanced molecular diagnostics in emerging markets.
CrisprBits funding captured (1)
| Deal type | Stage | Date | Amount | Investors |
|---|---|---|---|---|
| Equity | Pre-Seed | Nov 25, 2025 | $3.0m |